Hansen, Ronald

Hansen, Ronald W. 1979. The Pharmaceutical Development Process Estimates of Development Costs and Times and the Effects of Proposed Regulatory Changes, in Issues in Pharmaceutical Economics, ed. Robert I. Chien, 151-187. Boston Lexington Books. 

Lasagna, Louis Wardell, William and Hansen, Ronald, "Technological Innovation and Government Regulation of Pharmaceuticals in the U.S. and Great Britain", National Science Foundation Grant No. RDA-75 19066-00, University of Rochester, Rochester, New York, 1977. 

DiMasi, Joseph A., Hansen, Ronald W., Grabowski, Henry G. and Lasagna, Louis, Research and Development Costs for New Drugs by Therapeutic Category A Study of the U.S. Pharmaceutical Industry, Pharmacoeconomics, February 1995. 

Hansen, Ronald. 2006. KKK Backing Welcomed. Detroit News, November 4. http //www.detnews.com/apps/pbcs.dll/article AID=/20061104/POLI TICSOl/611040362/1022/POLITICS. 

DiMasi, Joseph A., Ronald W. Hansen, and Henry G. Grabowski. The Price of Innovation New Estimates of Drug Development Costs. Journal of Health Economics 22 (2003) 151-185. The researchers estimate that a new drug cost about 800 million to develop. 

This project-level approach was used in a pair of studies pioneered by Ronald Hansen (175) and updated and extended by Joseph DiMasi and colleagues (109). The frequent contention by industry spokesmen that it costs 231 million (in 1987 constant dollars) to bring an NCE to market (326) is the central result of the DiMasi study (109). In 1990 constant dollars, the cost would be 259 million.10... 

Ronald W. Hansen Associate Dean for Academic Affairs University of Rochester Rochester, NY Lakshmi Shyam-Sunder Assistant Professor of Business Administration Dartmouth College Hanover, NH... 

---